for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-GlaxoSmithKline Inc Says Trelegy Ellipta Approved In Canada

April 5 (Reuters) - GlaxoSmithKline Inc:

* TRELEGY ELLIPTA APPROVED IN CANADA AS FIRST INHALER FOR LONG-TERM, ONCE DAILY TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

* TRELEGY ELLIPTA AVAILABILITY IS EXPECTED JUNE 2018 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up